Thinking outside the Box: Non-Canonical Targets in Multiple Sclerosis

Scientists highlight non-canonical targets in preclinical multiple sclerosis research with a focus on five highly promising areas: oligodendrocytes, the blood–brain barrier, metabolites and cellular metabolism, the coagulation system, and tolerance induction.